<?xml version="1.0" encoding="UTF-8"?>
<ref id="B11-molecules-25-04677">
 <label>11.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Vatsadze</surname>
    <given-names>S.Z.</given-names>
   </name>
   <name>
    <surname>Eremina</surname>
    <given-names>O.E.</given-names>
   </name>
   <name>
    <surname>Veselova</surname>
    <given-names>I.A.</given-names>
   </name>
   <name>
    <surname>Kalmykov</surname>
    <given-names>S.N.</given-names>
   </name>
   <name>
    <surname>Nenajdenko</surname>
    <given-names>V.G.</given-names>
   </name>
  </person-group>
  <article-title>18F-Labelled catecholamine type radiopharmaceuticals in the diagnosis of neurodegenerative diseases and neuroendocrine tumours: Approaches to synthesis and development prospects</article-title>
  <source>Russ. Chem. Rev.</source>
  <year>2018</year>
  <volume>87</volume>
  <fpage>350</fpage>
  <lpage>373</lpage>
  <pub-id pub-id-type="doi">10.1070/RCR4752</pub-id>
 </element-citation>
</ref>
